Tuberous sclerosis associated with MDR1 gene expression and drug- resistant epilepsy

Pediatric Neurology

Volumn 21, Issue 4, 1999, Pages 731-734

  Lazarowski, Alberto ^a   Sevlever, Gustavo ^a   Taratuto, Analía ^a   Massaro, Mario ^a   Rabinowicz, Adrián ^a  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; GLYCOPROTEIN P; LORAZEPAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ANTICONVULSANT THERAPY; ARTICLE; BRAIN SURGERY; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; GENE EXPRESSION; GENETIC RESISTANCE; HUMAN; HUMAN TISSUE; INFANT; INTRACTABLE EPILEPSY; INTRAVENOUS DRUG ADMINISTRATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIODIAGNOSIS; TREATMENT FAILURE; TUBEROUS SCLEROSIS;

ANTICONVULSANTS; BIOPSY; BRAIN; DRUG RESISTANCE, MULTIPLE; EPILEPSY; FEMALE; GENE EXPRESSION; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; P-GLYCOPROTEIN; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

EID: 0032723612     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(99)00074-0     Document Type: Article

References (15)

1. Consensus conference Surgery for epilepsy . JAMA. 264:1990;729-733.
2. Biedler N., Riehm W. Cellular resistance to actinomycin D hamster cells in vitro Cross resistance, radioautographic, and cytogenetics studies . Cancer Res. 30:1990;1174-1184.
3. Ling V. Does P-glycoprotein predict response to chemotherapy? J Natl Cancer Inst. 81:1989;84-85.
4. Gottesman M.M., Pastan I. The multidrug transporter, a double-edge sword. J Biol Chem. 263:1988;12163-12166.
5. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem. 62:1993;385-427.
6. Schort M.P., Richardson E. Jr, Haines J.L., Kwiatkowski D. Clinical neuropathological and genetic aspects of tuberous sclerosis complex. Brain Pathol. 5:1995;173-179.
7. Cordon-Cardo C. Immunohistochemical analysis of P-glycoprotein expression in normal and tumor tissues in humans. Roninson I.B. Molecular and cellular biology of multidrug resistance in tumor cells. 1991;303-318 Plenum Press, New York.
8. Phuphanich S., Lomartire M., DeConti R. Is early complete response in recurrent malignant gliomas treated with cisplatin, VP-16, and vincristine related to anticonvulsant? Ann Neurol. 4:1996;490.
9. Tishler D., Weinberg K., Hinton D., Barbaro N., Geralyn A., Corey R. MDR1 gene expression in brain of patient with medically intractable epilepsy. Epilepsia. 36:1995;1-6.
10. D'Giano C., Sevlever G., Lazarowski A., et al. Expression of P-glycoprotein and related proteins in brain of patients with refractory temporal lobe epilepsy. Epilepsia. 38:(Suppl 87):1997;8.
11. Woodbury D. Phenytoin Absorption, distribution and excretion . Levy R., Mattson R., Melfrum B., Penry J.K., Dreifuss F.E. Antiepileptic drugs. 1989;177-195 Raven Press, New York.
12. Luker G., Fracasso P., Dobkin J., Piwnica-Worms D. Modulation of the multidrug resistance P-glycoprotein Detection with technetium-99m-Sestamibi in vivo . J Nucl Med. 38:1997;369-372.
13. Roach E.S., Smith M., Huttenlocher P., Bhat M., Alcorn D., Hawley L. Diagnostic criteria Tuberous sclerosis complex: Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association . J Child Neurol. 7:1992;221-224.
14. Holyoake T.L., Alcorn M.J. CD34+ positive haematopoietic cells. Biology and clinical applications. Blood Rev. 8:1994;113-124.
15. Voigt A., Häfer R., Gruhn B., Zintl F. Expression of CD34 and other haematopoietic antigens on neuroblastoma cells Consequences for autologous bone marrow and peripheral blood stem cell transplantation . J Neuroimmunol. 78:1997;117-126.